QYUNS-B (02509) spent 998,200 Hong Kong dollars to repurchase 49,200 shares on November 21.
Quanshun Biological-B (02509) announced that it will spend 998,200 Hong Kong dollars to repurchase... on November 21, 2025.
QYUNS-B (02509) announced on November 21, 2025 that it would spend HK$ 998,200 to repurchase 49,200 shares.
Related Articles
FEG HOLDINGS (01413) intends to implement a "5-in-1" stock consolidation and change the minimum trading unit.
BAIC MOTOR (01958) plans to sell 51% of its equity in BAIC International for approximately 1.608 billion yuan.
CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.
FEG HOLDINGS (01413) intends to implement a "5-in-1" stock consolidation and change the minimum trading unit.
BAIC MOTOR (01958) plans to sell 51% of its equity in BAIC International for approximately 1.608 billion yuan.
CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.
